Extract
Antibody-mediated rejection (AMR) after lung transplantation (LTx) is associated with poor prognosis [1]. Recent ISHLT recommendation propose a standardised classification of lung AMR [2]. Based on the number of features present, these classification describe three different degree of certainty for the AMR diagnosis. However in the absence of a true gold standard, the management of potential AMR rely on a quite high degree of uncertainty.
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr PARQUIN has nothing to disclose.
Conflict of interest: Dr Cuquemelle has nothing to disclose.
Conflict of interest: Dr Camps has nothing to disclose.
Conflict of interest: Dr Devaquet has nothing to disclose.
Conflict of interest: Dr Sage has nothing to disclose.
Conflict of interest: Dr Longchampt has nothing to disclose.
Conflict of interest: Dr MALARD has nothing to disclose.
Conflict of interest: Dr Picard has nothing to disclose.
Conflict of interest: Dr taupin has nothing to disclose.
Conflict of interest: Dr Roux has nothing to disclose.
Conflict of interest: Dr Leguen has nothing to disclose.
Conflict of interest: Dr Phillips-Houlbracq has nothing to disclose.
Conflict of interest: Dr Brugiere has nothing to disclose.
- Received June 26, 2019.
- Accepted December 22, 2019.
- Copyright ©ERS 2020
INDIVIDUALS
Log in using your username and password
LIBRARY USERS
Log in through your institution
Purchase access
CONTACT US
If you have any questions about the ERS publications website, please contact journals@ersnet.org